Intra-pleural fibrinolytic therapy versus placebo, or a different fibrinolytic agent, in the treatment of adult parapneumonic effusions and empyema

Cochrane Database of Systematic Reviews

Volumn 2019, Issue 10, 2019, Pages

  Altmann, Emile S ^a   Crossingham, Iain ^b   Wilson, Stephen ^b   Davies, Huw R ^c  

^a JOHN HUNTER HOSPITAL   (Australia)

^b EAST LANCASHIRE HOSPITALS NHS TRUST   (United Kingdom)

^c Sleep Health Service   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ALTEPLASE; FIBRINOLYTIC AGENT; STREPTOKINASE; UROKINASE; ANTIINFECTIVE AGENT; TISSUE PLASMINOGEN ACTIVATOR;

ADULT; CLINICAL EFFECTIVENESS; CLINICAL OUTCOME; CONSERVATIVE TREATMENT; DRUG EFFECT; DRUG EFFICACY; DRUG RESPONSE; EVIDENCE BASED PRACTICE; FIBRINOLYSIS; FOLLOW UP; HOSPITAL DISCHARGE; HUMAN; MORTALITY RATE; PARAPNEUMONIC EFFUSION; PATIENT REFERRAL; PLEURA DISEASE; PLEURA EMPYEMA; PRIORITY JOURNAL; REVIEW; SYSTEMATIC REVIEW; TREATMENT FAILURE; FIBRINOLYTIC THERAPY; META ANALYSIS; PLEURA EFFUSION; PROCEDURES; RANDOMIZED CONTROLLED TRIAL (TOPIC);

ANTI-BACTERIAL AGENTS; DRAINAGE; EMPYEMA, PLEURAL; FIBRINOLYTIC AGENTS; HUMANS; PLEURAL EFFUSION; RANDOMIZED CONTROLLED TRIALS AS TOPIC; STREPTOKINASE; THROMBOLYTIC THERAPY; TISSUE PLASMINOGEN ACTIVATOR; UROKINASE-TYPE PLASMINOGEN ACTIVATOR;

EID: 85074357953     PISSN: 14651858     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD002312.pub4     Document Type: Review

References (80)

1. Aleman C, Porcel JM, Alegre J, Ruiz E, Bielsa S, Andreu J, et al. Intrapleural fibrinolysis with urokinase versus alteplase in complicated parapneumonic pleural effusions and empyemas: a prospective randomized study. Lung 2015;193(6):993-1000.
2. Bouros D, Schiza S, Patsourakis G, Chalkiadakis G, Panagou P, Siafakas N. Intrapleural streptokinase versus urokinase in the treatment of complicated parapneumonic effusions. American Journal of Respiratory and Critical Care Medicine 1997;155(1):291-5.
3. Bouros D, Schiza S, Tzanakis N, Chalkiadakis G, Drositis J, Siafakas N. Intrapleural urokinase versus normal saline in the treatment of complicated parapneumonic effusions and empyema. American Journal for Respiratory and Critical Care Medicine 1999;159(1):37-42.
4. Bouros D, Schiza SE, Drositis J, Tzanakis N, Papalexatos S, Mitrouska I, et al. Control study of intrapleural instillation of urokinase in the treatment of multi-loculated pleural effusion and empyema. American Journal of Respiratory and Critical Care Medicine 1998;157(3 Suppl):A65.
5. Schiza S, Bouros D, Maltezakis G, Drositis J, Tzanakis N, Siafakas NM. Intrapleural urokinase vs normal saline in the treatment of thoracic empyema: a randomized double blind study. European Respiratory Journal 1997;10(Suppl 25):455s.
6. Davies RJ, Traill ZC, Gleeson FV. Randomised controlled trial of intrapleural streptokinase in community acquired pleural infection. Thorax 1997;52(5):416-21.
7. Diacon AH, Theron J, Schuurmans MM, Van de Wal BW, Bolliger CT. Intrapleural streptokinase for empyema and complicated parapneumonic effusions. American Journal of Respiratory and Critical Care Medicine 2004;170(1):49-53.
8. Lin J-C, Zhang C-R, Li M, Zhou H, Niu Y-Y, Liu X-Y. Effectiveness and safety of intrapleural tissue plasminogen activator in the prevention of pleural thickening and loculated pleural effusions. Chinese Journal of Clinicians 2011;5(9):2610-14.
9. Lin J-C, Zhang C-R, Xu W-M, Li M, Cui W-L. Effectiveness and safety of intrapleural tissue plasminogen activator in the prevention of pleural thickening and loculated effusions by infective pleurisy. International Journal of Infectious Diseases 2011;15(suppl 1):S104-5.
10. Maskell NA, Davies CW, Nunn AJ, Hedley EL, Gleeson FV, Miller R, et al. U.K. controlled trial of intrapleural streptokinase for pleural infection. New England Journal of Medicine 2005;352(9):865-74.
11. Misthos P, Sepsas E, Konstantinou M, Athanassiadi K, Skottis I, Lioulias A. Early use of intrapleural fibrinolytics in the management of postpneumonic empyema. A prospective study. European Journal of Cardio-thoracic Surgery 2005;28(4):599-603.
12. Prasad BNBM, Bhattacharyya D, Luthra M, Mathur AD. Management of empyema thoracis with pleural pigtail drainage and intrapleural thrombolytic therapy [Abstract]. American Journal of Respiratory and Critical Care Medicine 2009;179:A4486 [Poster #G115].
13. Rahman NM, Maskell NA, West A, Teoh R, Arnold A, Mackinlay C, et al. Intrapleural use of tissue plasminogen activator and DNase in pleural infection. New England Journal of Medicine 2011;365(6):518-26.
14. Thommi G, Shehan JC, Robison KL, Christensen M, Backemeyer LA, McLeay MT. A double blind randomized cross over trial comparing rate of decortication and efficacy of intrapleural instillation of alteplase vs placebo in patients with empyemas and complicated parapneumonic effusions. Respiratory Medicine 2012;106(5):716-23.
15. Tuncozgur B, Ustunsoy H, Dikensoy O, Topal M, Sanli M, Elbeyli L. Intrapleural urokinase in the management of parapneumonic empyema: a randomised controlled trial. International Journal of Clinical Practice 2001;55(10):658-60.
16. Anonymous. 21st Congress of the Asian Pacific Society of Respirology; 2016 Nov 12-15; Bangkok. 2016; Vol. 21:S3.
17. Anonymous. CHEST 2019 Regional Congress Abstracts. Chest 2019; Conference: CHEST 2019 Regional Congress. Greece. 155(6 Supplement):A327-88.
18. Ayed A, Shehab D. Role of intrapleural tissue plasminogen in management of complicated pleural effusion. Cardiothoracic Surgery 2013;144(4):108A.
19. Bachmayer K. Tissue plasminogen activator and DNase in empyema. New England Journal of Medicine 2011;365(20):1936; author reply 1936-7.
20. Bashir M, Mousbah H, Gdeedo A. Effectiveness and safety of tissue plasminogen activators (t-PA) in complicated pleural effusion (CPE), what is the correlation with time it stays in the pleural space?. European Respiratory Journal 2013;42:5040.
21. Beckert L, Brockway B, Simpson G, Southcott AM, Lee YCG, Rahman N, et al. Phase 1 trial of intrapleural LTI-01; single chain urokinase in complicated parapneumonic effusions or empyema. JCI Insight 2019;4(10):e127470.
22. Bilaçeroglu S, Cagirici U, Cakan A, Kumcuoglu Z, Perim K. Management of complicated parapneumonic pleural effusions with image-guided drainage and intrapleural urokinase or streptokinase: a controlled randomized trial. European Respiratory Journal 10;Suppl 25:325s.
23. Bouros D, Antoniou KM, Light RW. Intrapleural streptokinase for pleural infection. BMJ 2006;332(7534):133-4.
24. Cases Viedma E, Lorenzo Dus MJ, Gonzalez-Molina A, Sanchis Aldas JL. A study of loculated tuberculous pleural effusions treated with intrapleural urokinase. Respiratory Medicine 2006;100(11):2037-42.
25. Chin NK, Lim T. Controlled trial of intrapleural streptokinase in the treatment of pleural empyema and complicated parapneumonic effusions. Chest 1997;111(2):275-9.
26. Lim TK, Chin NK. Empirical treatment with fibrinolysis and early surgery reduces the duration of hospitalization in pleural sepsis. European Respiratory Journal 1999;13(3):514-8.
27. Chung CL, Chen YC, Chang SC. Effect of repeated thoracenteses on fluid characteristics, cytokines, and fibrinolytic activity in malignant pleural effusion. Chest 2003;123(4):1188-95.
28. Chung CL, Chen CH, Yeh CY, Sheu JR, Chang SC. Early effective drainage in the treatment of loculated tuberculous pleurisy. European Respiratory Journal 2008;31(6):1261-7.
29. CTRI/2018/08/015361. Empyema of lung treatment. www.who.int/trialsearch/Trial2.aspx? TrialID=CTRI/2018/08/015361 2018.
30. Fernández Fernández A, Giachetto Larraz G, Giannini Fernandez G, Garat Gomez MC, Vero Acevedo MA, Pastorini Correa J, et al. Intrapleural streptokinase in the treatment of complicated parapneumonic empyema. Anales de Pediatria (Barcelona, Spain: 2003) 2007;66(6):585-90.
31. Fester A. Revisiting intrapleural fibrinolysis in empyema. Thorax 2012;67(4):308.
32. Froudarakis ME, Kouliatsis G, Steiropoulos P, Anevlavis S, Pataka A, Popidou M, et al. Recombinant tissue plasminogen activator in the treatment of pleural infections in adults. Respiratory Medicine 2008;102(12):1694-700.
33. ISRCTN12852177. A randomised controlled trial to evaluate whether use of intrapleural urokinase aids the drainage of multi-septated pleural effusion compared to placebo. www.who.int/trialsearch/Trial2.aspx?TrialID=ISRCTN12852177 2008.
34. Jin JM, Sun YC. [Evaluation of febrinolytic therapy for treatment of pleural infection]. [Chinese]. Zhonghua Jie He He Hu Xi Za Zhi 2013;36(5):327-9.
35. Komissarov AA, Florova G, Schaefer C, Rahman NM, Lee YCG, Idell S. Pleural fluids collected during the second multicenter intrapleural sepsis trial (MIST2) demonstrate highly variable fibrinolytic potential prior to the treatment and endogenous fibrinolytic activity depletion during intrapleural fibrinolytic therapy. American Journal of Respiratory and Critical Care Medicine 2013;187:A4313.
36. Light RW. Management of parapneumonic effusions. Journal of Clinical and Analytical Medicine 2010;1(2):48-51.
37. Lim TK, Chin NK. Empirical treatment with fibrinolysis and early surgery reduces the duration of hospitalization in pleural sepsis. European Respiratory Journal 1999;13(3):514-8. [PUBMED: 10232418]
38. Maiga A, Pinkerman R, Deppen SA, Scruggs J, Mcguire P, Tarpley JL, et al. tPA/DNase for Complicated Parapneumonic Effusions and Empyemas. American Surgeon 2017;83(12):1458-9.
39. Maskell N, Nunn A, Davies RJ. Intrapleural streptokinase for pleural infection. BMJ 2006;332(7540):552.
40. Masood I, Bhargava R, Ahmad Z, Pandey DK, Ahmad S. Role of intrapleural streptokinase in empyema. Journal, Indian Academy of Clinical Medicine: JIACM 2006;7(4):313-5.
41. Mathur PN. Intrapleural t-PA plus DNase improved clinical outcomes in patients with pleural infection. Annals of Internal Medicine 2011;155(12):JC6-9.
42. Muers MF. Streptokinase for empyema. Lancet 1997;349(9064):1491-2.
43. NCT00103766. Randomized comparison of two dose and frequency regimens of alteplase for treatment of empyema and complicated parapneumonic effusion. clinicaltrials.gov/ct2/ show/NCT00103766 (First received February 15 2005).
44. NCT01862458. Empyema Treated With tPA & DNAse. clinicaltrials.gov/show/NCT01862458 2013.
45. NCT02973139. Fibrinolysis Compared to Thoracoscopy for Pleural Infection. clinicaltrials.gov/show/NCT02973139 2016.
46. NCT03172052. Evaluating Different Modalities for Pleural Adhesiolysis at Assuit University Hospital. clinicaltrials.gov/ show/nct03172052 2017.
47. Ruiz A, Porcel JM, Madronero AB, Galindo C. Hemothorax following administration of intrapleural alteplase. Respiration 2006;73(5):715.
48. Shah NN, Bachh AA, Bhargava R, Ahmad Z, Panday DK, Shameem Mohd. Role of intrapleural streptokinase in management of multiloculated thoracic empyemas. JK Practitioner 2006;13(2):91-4.
49. Skeete DA, Rutherford EJ, Schlidt SA, Abrams JE, Parker LA, Rich PB. Intrapleural tissue plasminogen activator for complicated pleural effusions. Journal of Trauma 2004;57(6):1178-83.
50. Talib SH, Verma GR, Arshad M, Tayade BO, Rafeeque A. Utility of intrapleural streptokinase in management of chronic empyemas. Journal of the Association of Physicians of India 2003;51:464-8.
51. Tsang KY, Leung WS, Chan VL, Lin AW, Chu CM. Complicated parapneumonic effusion and empyema thoracis: microbiology and predictors of adverse outcomes. Hong Kong Medical Journal 2007;13(3):178-86.
52. Wong K-S. Is intrapleural streptokinase instillation a routine for parapneumonic empyema?. Acta Paediatrica Taiwanica 2006;47(2):59-60.
53. Zuckerman DA, Reed MF, Howington JA, Moulton JS. Efficacy of intrapleural tissue-type plasminogen activator in the treatment of loculated parapneumonic effusions. Journal of Vascular and Interventional Radiology 2009;20(8):1066-9.
54. Chung CL, Chen CH, Sheu JR, Chen YC, Chuang SC. Proinflammatory cytokines, transforming growth factor-beta1, and fibrinolytic enzymes in loculated and free-flowing pleural exudates. Chest 2005;128(2):690-7.
55. Davies HE, Davies RJO, Davies CWH. Management of pleural infection in adults: British Thoracic Society pleural disease guideline 2010. Thorax 2010;65(Suppl 2):ii41-ii53.
56. Farjah F, Symons RG, Krishnadasan B, Wood DE, Flum DR. Management of pleural space infections: a population-based analysis. Journal of Thoracic and Cardiovascular Surgery 2007;133(2):346-51.
57. McMaster University (developed by Evidence Prime). GRADEpro GDT. Hamilton (ON): McMaster University (developed by Evidence Prime), (accessed before 18 September 2019).
58. Grijalva CG, Zhu Y, Nuorti JP, Griffin MR. Emergence of parapneumonic empyema in the USA. Thorax 2011;66(8):663-8.
59. Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org.
60. Idell S, Girard W, Koenig KB, McLarty J, Fair DS. Abnormalities of pathways of fibrin turnover in the human pleural space. American Review of Respiratory Disease 1991;144(1):187-94.
61. Idell S. Update on the use of fibrinolysins in pleural disease. Clinical Pulmonary Medicine 2005;12(3):184-90.
62. Janda S, Swiston J. Intrapleural fibrinolytic therapy for treatment of adult parapneumonic effusions and empyemas: a systematic review and meta-analysis. Chest 2012;142(2):401-11.
63. LeMense PG, Strange C, Sahn SA. Empyema thoracis. Therapeutic management and outcome. Chest 1995;107(6):1532-7.
64. Light RW. Parapneumonic effusion and empyema. Clinical Chest Medicine 1985;6(1):55-62.
65. Light RW, Nguyen T, Mulligan ME, Sasse SA. The in vitro efficacy of varidase versus streptokinase or urokinase for liquefying thick purulent exudative material from loculated empyema. Lung 2000;178(1):13-8.
66. Nie W, Liu Y, Ye J, Shi L, Shao F, Ying K, Zhang R. Efficacy of intrapleural instillation of fibrinolytics for treating pleural empyema and parapneumonic effusion: a meta-analysis of randomized control trials.. Clinical Respiratory Journal 2014;8(3):281-91.
67. Piccolo F, Popowicz N, Wong D, Lee YCG. Intrapleural tissue plasminogen activator and deoxyribonuclease therapy for pleural infection. Journal of Thoracic Diseases 2015;7(6):999-1008.
68. Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager 5 (RevMan 5). Version 5.3. Copenhagen: Nordic Cochrane Centre, The Cochrane Collaboration, 2014.
69. Sahn SA. Management of complicated parapneumonic effusions. American Review of Respiratory Disease 1993;148(3):813-7.
70. Scarcia M, Abaha U, Piergiorgio S, Pagea A, Wallerb D, van Schilc P, et al. EACTS expert consensus statement for surgical management of pleural empyema. European Journal of Cardiothoracic Surgery 2015;48(5):642-53.
71. Shen KR, Bribiesco A, Crabtree T, Denlinger C, Eby J, Eiken, P, et al. The American Association of Thoracic Surgery consensus guidelines for the management of empyema. Journal of Thoracic and Cardiovascular Surgery 2017;153(6):e129-e146.
72. Singh M, Mathew JL, Chandra S, Katariya S, Kumar L. Randomised controlled trial of intrapleural streptokinase in empyema thoracis in children. Acta Paediatrica 2004;93(11):1443-5.
73. Strange C, Sahn SA. The definitions and epidemiology of pleural space infection. Seminars in Respiratory Infections 1999;14(1):3-8. [PUBMED: 10197392]
74. Thommi G, Shehan C, Bell A, Coughlin N, McLeay M. Intrapleural instillation of TPA in the management of complicated pleural effusions. Chest 2000;118(Suppl 4):S164.
75. Thomson AH, Hull J, Kumar MR, Wallis C, Balfour Lynn IM. Randomised controlled trial of intrapleural urokinase in the treatment of childhood empyema. Thorax 2002;57(4):343-7.
76. Tillett WS, Sherry S, Read CT. The use of streptokinase-streptodornase in the treatment of post-pneumonic empyema. Journal of Thoracic Surgery 1951;21(3):275-97.
77. Walker CA, Shirki MB, Marva MT, Visconti J. Intrapleural alteplase in a patient with complicated pleural effusion. Annals of Pharmacotherapy 2003;37(3):376-9.
78. Cameron R, Davies H. Intra-pleural fibrinolytic therapy for parapneumonic effusions and empyema. Cochrane Database of Systematic Reviews 1999, Issue 4. [DOI: 10.1002/14651858.CD002312]
79. Cameron R, Davies HR. Intra-pleural fibrinolytic therapy versus conservative management in the treatment of parapneumonic effusions and empyema. Cochrane Database of Systematic Reviews 2004, Issue 1. [DOI: 10.1002/14651858.CD002312.pub2]
80. Cameron R, Davies HR. Intra-pleural fibrinolytic therapy versus conservative management in the treatment of adult parapneumonic effusions and empyema. Cochrane Database of Systematic Reviews 2008;16(2):CD002312.